New PBS listing for migalastat (Galafold) for the treatment of Fabry disease

19 August 2024 - On 1 September 2024, migalastat hydrochloride (Galafold) will become available on the PBS for the treatment ...

Read more →

Most expensive treatments remain out of reach without health reform

18 August 2024 - Patients are waiting nearly 600 days to access medicines to which the Therapeutic Goods Administration has ...

Read more →

Cheaper medicines for rare genetic disorders and cancer

12 August 2024 - Adults with hereditary transthyretin-mediated amyloidosis and with certain cancers, will now have access to cheaper medicines ...

Read more →

PBS listing for Australians with hereditary transthyretin-mediated amyloidosis with polyneuropathy

1 August 2024 - Medison Pharma, alongside their partner Alnylam Pharmaceuticals, are pleased to announce that from 1 August 2024, ...

Read more →

Groundbreaking therapy for terminal cancers finally publicly funded

2 August 2024 - A groundbreaking pan-tumour pharmaceutical that can act upon multiple different tumour types has been publicly funded ...

Read more →

Agenda for the November 2024 PBAC meeting (version 1)

31 July 2024 - The agenda for the November 2024 PBAC meeting is now available. ...

Read more →

Life-changing cancer treatment jab added to PBS

31 July 2024 - Australians fighting lung and liver cancer will soon be able to access a life-saving cancer treatment ...

Read more →

Schedule of Pharmaceutical Benefits - 1 August 2024

1 August 2024 - The August 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Life changing medicine for children with cystic fibrosis

29 July 2024 - Australian children with cystic fibrosis now have access to cheaper medicines earlier under the PBS thanks ...

Read more →

Why 10,000 Aussies a year being forced to fund their own cancer treatment

21 July 2024 - Australia’s medicine subsidy scheme is so crippled that a staggering 10,000 patients a year are being forced ...

Read more →

Public Summary Documents (first time decisions not to recommend and deferrals) - March 2024 PBAC meeting

19 July 2024 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the March 2024 ...

Read more →

DUSC utilisation analysis public release documents (June 2024)

19 July 2024 - The utilisation analysis public release documents from the June 2024 DUSC meeting are now available. ...

Read more →

Outcome statement - June 2024 DUSC meeting

19 July 2024 - The outcome statement from the June 2024 DUSC meeting is now available. ...

Read more →

Australian children with neuroblastoma given free access to 500,000 dollar cancer drug DFMO

10 July 2024 - Australian children and young adults with neuroblastoma, a cancer that affects the nervous system, will be ...

Read more →

Updates to the HTA Policy and Methods Review

10 July 2024 - The Health Technology Assessment (HTA) Policy and Methods Review concluded on 4 May 2024. The HTA ...

Read more →